Dimeric IAP antagonists

Details for Australian Patent Application No. 2012202098 (hide)

Owner Tetralogic Pharmaceuticals Corporation

Inventors Deng, Yijun; Condon, Stephen M.; Laporte, Matthew G.; Rippin, Susan R.

Agent Pizzeys

Pub. Number AU-A-2012202098

Parent 2007276760

Filing date 12 April 2012

Wipo publication date 3 May 2012

International Classifications

C07K 5/06 (2006.01) Peptides having up to four amino acids in a fully defined sequence

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

26 April 2012 Complete Application Filed

3 May 2012 Application Open to Public Inspection

  Published as AU-A-2012202098

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2012202099-Combined vaccines comprising hepatitis B surface antigen and other antigens

2012202097-Method of assessing infection status